Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3,273 JPY | +1.49% | -6.08% | +3.87% |
Apr. 11 | Aeon's Sales Grow 5% in March | MT |
Apr. 11 | Aeon to Renew 'Poison Pill' Strategy | MT |
Sales 2024 | 9,554B 61.84B | Sales 2025 * | 9,874B 63.92B | Capitalization | 2,760B 17.87B |
---|---|---|---|---|---|
Net income 2024 | 44.69B 289M | Net income 2025 * | 48.18B 312M | EV / Sales 2024 | 0.32 x |
Net Debt 2024 * | 2,034B 13.17B | Net Debt 2025 * | 2,375B 15.37B | EV / Sales 2025 * | 0.52 x |
P/E ratio 2024 |
68.4
x | P/E ratio 2025 * |
57.2
x | Employees | 400,000 |
Yield 2024 |
1.01% | Yield 2025 * |
1.15% | Free-Float | 86.22% |
Latest transcript on Aeon Co., Ltd.
1 day | +1.49% | ||
1 week | -2.24% | ||
Current month | -8.96% | ||
1 month | -7.98% | ||
3 months | -6.67% | ||
6 months | +7.03% | ||
Current year | +3.87% |
Managers | Title | Age | Since |
---|---|---|---|
Akio Yoshida
PSD | President | 63 | 83-03-31 |
Director of Finance/CFO | 70 | 77-03-31 | |
Motoya Okada
CHM | Chairman | 72 | 79-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Motoya Okada
CHM | Chairman | 72 | 79-02-28 |
Director/Board Member | 73 | 17-04-30 | |
Director of Finance/CFO | 70 | 77-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
7.81% | 10 M€ | +7.96% | ||
0.84% | 174 M€ | -.--% | - | |
0.84% | 51 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 3,273 | +1.49% | 1 524 700 |
24-04-17 | 3,225 | -1.13% | 1,969,200 |
24-04-16 | 3,262 | -2.07% | 2,201,200 |
24-04-15 | 3,331 | +0.57% | 2,112,100 |
24-04-12 | 3,312 | -1.08% | 3,202,100 |
Delayed Quote Japan Exchange, April 18, 2024 at 02:00 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.87% | 17.85B | |
+13.51% | 481B | |
+20.89% | 39.88B | |
+3.16% | 37.56B | |
+16.16% | 33.01B | |
+4.09% | 27.32B | |
-14.65% | 24.93B | |
-2.41% | 24.48B | |
+7.85% | 17.26B | |
-1.79% | 13.43B |
- Stock Market
- Equities
- 8267 Stock